Avalynpharma

Avalyn Pharma is a clinical-stage biotechnology company developing inhaled therapies for rare and serious respiratory diseases, with a focus on idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases. Its inhaled-delivery pipeline includes AP01 (inhaled pirfenidone), AP02 (inhaled nintedanib), and AP03 (a fixed-dose combination), aiming to deliver antifibrotic medication directly to lung tissue to improve efficacy while reducing systemic side effects. Backed by Norwest Venture Partners, the company is a therapeutics developer and publishes no public API or developer surface; this profile is maintained in the API Evangelist network as a company record.

Avalynpharma is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Clinical Stage, and Respiratory.

Avalynpharma’s developer surface includes support and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

14.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPharmaceuticalsClinical StageRespiratoryPulmonary FibrosisInhaled TherapeuticsLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 14.6/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.9 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/avalynpharma: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: avalynpharma
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/avalynpharma.png
name: Avalynpharma
description: Avalyn Pharma is a clinical-stage biotechnology company developing inhaled therapies for rare and serious respiratory
  diseases, with a focus on idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases. Its inhaled-delivery
  pipeline includes AP01 (inhaled pirfenidone), AP02 (inhaled nintedanib), and AP03 (a fixed-dose combination), aiming to
  deliver antifibrotic medication directly to lung tissue to improve efficacy while reducing systemic side effects. Backed
  by Norwest Venture Partners, the company is a therapeutics developer and publishes no public API or developer surface; this
  profile is maintained in the API Evangelist network as a company record.
url: https://raw.githubusercontent.com/api-evangelist/avalynpharma/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- norwest-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Clinical Stage
- Respiratory
- Pulmonary Fibrosis
- Inhaled Therapeutics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/avalynpharma-domain-security.yml
- type: Website
  url: https://avalynpharma.com
- type: Support
  url: https://www.avalynpharma.com/contact/
- type: PrivacyPolicy
  url: https://www.avalynpharma.com/privacy-policy/
- type: TermsOfService
  url: https://www.avalynpharma.com/terms-of-use/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence